ESTRO35 Programme Book

POSTERS

> Hydrogel injection prevents long-term rectal toxicity after radiotherapy for prostate cancer M. Pinkawa (Germany), V. Schmitt, V. Djukic, J. Klotz, L. König, D. Frank, B. Krenkel, M. Eble > IMRT versus 3D conformal radiotherapy when used in combination with I-125 prostate brachytherapy A. Yorozu (Japan), T. Tanaka, R. Kota, Y. Takagawa, Y. Shiraishi, K. Toya, S. Saito > Nodal clearance rate and efficacy of individualised SN-based pelvic IMRT for prostate cancer A. Müller (Germany), F. Eckert, F. Paulsen, D. Zips, A. Stenzl, D. Schilling, M. Alber, R. Bares, P. Martus, D. Weckermann, C. Belka, U. Ganswindt > Even high-dose radiotherapy requires long-term androgen ablation for high-risk prostate cancer T.K. Nam (Republic of Korea), D.D. Kwon, J.W. Jeong, Y.H. Kim, M.S. Yoon, J.Y. Song, S.J. Ahn, W.K. Chung > Image-guided IMRT reduces late toxicity compared to 3D-CRT for prostate cancer R. Wortel (The Netherlands), L. Incrocci, F. Pos, U. Van der Heide, J. Lebesque, S. Aluwini, M. Witte, W. Heemsbergen > Stereotactic body radiotherapy in recurrent lymph nodes metastases from prostate cancer F. Trippa (Italy), E. Maranzano, E. Ponti, A. Carosi, F. Arcidiacono, L. Draghini, L. Di Murro, A. Lancia, P. Anselmo, R. Santoni, G. Ingrosso > Effects of IMRT or radical prostatectomy (RP) on serum testosterone in patients with prostate cancer A. Giraldo Marin (Spain), X. Maldonado, J. Planas, M. Hermida, M.J. Mañas, S. Mico, J. Morote, J. Giralt > Significant correlation between prostate volume and obstructive voiding symptom in hypofractionation S. Pérez Echagüen (Spain), C.J. Sanz Freire, G.A. Ossola Lentati

PO-0738

PO-0739

PO-0740

PO-0741

PO-0742

PO-0743

PO-0744

PO-0745

> Spanish validation of Charlson Index applied to prostate cancer F. Casas i Duran (Spain), F. Ferrer, A. Herreros, J. Saez, C. Camacho

PO-0746

POSTERS AND ELECTRONIC POSTERS | PROGRAMME AND EXHIBITION GUIDE

175